Alveolar macrophage status in bronchopulmonary dysplasia.
The predominant inflammatory cell type within the alveolar structure in bronchopulmonary dysplasia (BPD) is the alveolar macrophage (AM). AM ability to release hydrogen peroxide, a way to evaluate the cell status, was studied in nine infants who developed clinical and radiological evidence of BPD, and was compared to those from infants without lung parenchymal disorders (n = 6). AM were collected by bronchoalveolar lavage which was done after the mechanical ventilation stage in the BPD group. The experiments were performed on unstimulated AM and on AM stimulated by phorbol myristate acetate. Results revealed that the amount of hydrogen peroxide accumulated in the culture medium was significantly enhanced in the BPD group, in both experimental conditions (p less than 0.01 and less than 0.001, respectively). Furthermore, improvement of patients treated with glucocorticoids was closely related to a reduction of the alveolitis with a decrease of AM ability to generate hydrogen peroxide. These data indicate that AM activation is a central component of alveolitis in BPD and that extracellular production of oxidants by stimulated AM may play a critical role in the pathogenesis of the disease.
Clement
A
A
Pulmonary Department of Pediatrics, Hospital Trousseau, Paris, France.
Chadelat
K
K
Sardet
A
A
Grimfeld
A
A
Tournier
G
G
D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D002448:Cell Adhesion; D002478:Cells, Cultured; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D007223:Infant; D007231:Infant, Newborn; D011241:Prednisone / Q000627:therapeutic use*; D011650:Pulmonary Alveoli / Q000166:cytology / Q000276:immunology* / Q000378:metabolism
D006861:Hydrogen Peroxide; D011241:Prednisone